RFX FLUROSCOPIC DIGITAL IMAGING SYSTEM

K030544 · Sigma Vision, Inc. · OWB · May 21, 2003 · Radiology

Device Facts

Record IDK030544
Device NameRFX FLUROSCOPIC DIGITAL IMAGING SYSTEM
ApplicantSigma Vision, Inc.
Product CodeOWB · Radiology
Decision DateMay 21, 2003
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.1650
Device ClassClass 2

Intended Use

The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed. The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details difficult or impossible to see using conventional imaging techniques. The RFX system enables the operator to print hardcopy images with laser printers, or send images over a network. The major system components are: fluoroscopic CCD camera, monitors, and image processor.

Device Story

RFX Fluoroscopic Digital Imaging System captures video output from existing X-ray image intensifiers via a CCD camera. System digitizes, processes, and displays images on monitors. Processing features include brightness/contrast adjustment, edge enhancement, zoom, and subtraction. Used in clinical settings (general/interventional fluoroscopy, angiography, cardiac imaging) by healthcare professionals. Output stored locally, printed via laser printer, or transmitted via DICOM network. Enhances diagnostic detail beyond conventional film; facilitates clinical decision-making through improved visualization of anatomical structures.

Clinical Evidence

No clinical data provided; substantial equivalence based on technological characteristics and bench-level functional comparison to predicate devices.

Technological Characteristics

System comprises a fluoroscopic CCD camera, monitors, and an image processor. Operates by digitizing video output from an image intensifier. Supports 1000-line resolution and 1000x1000 digital spot acquisition. Connectivity via DICOM network. Software-based image processing includes brightness, contrast, edge enhancement, zoom, and subtraction.

Indications for Use

Indicated for patients undergoing general fluoroscopy, interventional fluoroscopy, angiography, or cardiac imaging procedures requiring high-resolution digital videography and spot imaging to replace conventional film techniques.

Regulatory Classification

Identification

An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Special Controls

*Classification.* Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # MAY 21 2003 K030544 # 510(K) Summary of Safety and Effectiveness #### Date Prepared: February 12, 2003 Name of Contact Person: Omid Kia Address: Sigma Vision Inc. 6001 Montrose Rd. Suite 606 Rockville, Md. 20852 . Phone: 301.770.0052 Fax: 240.209.0798 Device trade name: RFX Fluoroscopic Digital Imaging System Common name: Digital Radiography System Classification Name: Image intensified fluoroscopic X-ray system ### Device Description: The RFX fluoroscopic digital imaging system allows the use of digital imaging to be applied to conventional X-ray system used in general fluoroscopy, interventional fluoroscopy, angiography and cardiac imaging areas. The system works by installing a CCD camera on the output port of the imaging intensifier and digitizing the video output of the image intensifier. The digital image can be displayed on the monitor; it can be stored to the hard drive, or sent to an external device such as a laser imager or Dicom Network Service Provider. The image can also be processed, including brightness and contrast, edge enhancement, zoom, and subtraction. #### Intended Use: The RFX fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed. The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details difficult or impossible to see using conventional imaging techniques. The RFX system enables the operator to print hardcopy images with laser printers, or send images over a network. The major system components are: fluoroscopic CCD camera, monitors, and image processor. {1}------------------------------------------------ # Conclusion drawn from comparison: The RFX fluoroscopy digital imaging system can be considered to be substantially equivalent to: INFIMED Inc. GOLDONE Fluoroscopic System (510K) ~ K963037 CMT Medical Technologies. SPOT / RAD System (510K), K991578 and K003434 and, virtually all of the features offered by the predicate devices are offered by the RFX product. ## 510(k) Number: Unknown at this time #### Device Name: RFX Fluoroscopic Digital Imaging System. #### Indications for Use: The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed. The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details that might be difficult or impossible to see using conventional imaging techniques. Images can be stored locally for medium term storage. The RFX system enables the operator to print hardcopy images with a laser printer or send images over a network for longer term storage. The major system components include: a fluoroscopic CCD Camera, monitors, and an image processor PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, formed by three parallel lines that curve and taper to represent the feathers. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Omid Kia, Ph.D. Manager, Medical Imaging Products Sigma Vision, Inc. 6001 Montrose Rd., Suite 606 ROCKVILLE MD 20852 MAY - 7 2012 Re: K030544 Trade/Device Name: RFX Fluoroscopic Digital Imaging System Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: OWB and JAA Dated: February 12, 2003 Received: February 20, 2003 Dear Dr. Kia: This letter corrects our substantially equivalent letter of May 21, 2003. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of {3}------------------------------------------------ medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely Yours, Janine M. Morris Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ S10(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Device Name: REX Frusses seatis Dicerns fraging Indications For Use: #### Indications for Use: The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed. The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and cnhanced enabling the operator to bring out diagnostic details that might be difficult or impossible to see using conventional imaging techniques. Images can be stored locally for medium term storage. The RFX system enables the operator to print hardcopy images with a laser printer or send images over a network for longer term storage. The major system components include: a fluoroscopic CCD Camera, monitors, and an image processor (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Nancy C. Brogdon C (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number K030544 Prescription Use (Per 21 CFR 801.109) √ ത്ര OR Over-The-Counter Use (Optional Format 1-2-96)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%